Sources of Variability in Peak Expiratory Flow
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00005382 |
Recruitment Status
:
Completed
First Posted
: May 26, 2000
Last Update Posted
: May 13, 2016
|
Tracking Information | |||
---|---|---|---|
First Submitted Date | May 25, 2000 | ||
First Posted Date | May 26, 2000 | ||
Last Update Posted Date | May 13, 2016 | ||
Study Start Date | July 1995 | ||
Primary Completion Date | Not Provided | ||
Current Primary Outcome Measures | Not Provided | ||
Original Primary Outcome Measures | Not Provided | ||
Change History | Complete list of historical versions of study NCT00005382 on ClinicalTrials.gov Archive Site | ||
Current Secondary Outcome Measures | Not Provided | ||
Original Secondary Outcome Measures | Not Provided | ||
Current Other Outcome Measures | Not Provided | ||
Original Other Outcome Measures | Not Provided | ||
Descriptive Information | |||
Brief Title | Sources of Variability in Peak Expiratory Flow | ||
Official Title | Not Provided | ||
Brief Summary | To provide information necessary for the development of standards for peak expiratory flow (PEF) test performance in populations studies. | ||
Detailed Description | BACKGROUND: While PEF has routinely been applied in the diagnosis and management of asthma, scientists were finding new applications for PEF as both a clinical and epidemiologic tool for following individuals with pulmonary diseases, studying the natural history of chronic obstructive pulmonary disease, and evaluating the impact of environmental exposures on lung function. Yet the standardization of the PEF measurement lagged behind its application. The little attention paid to the performance characteristics of the PEF maneuver contrasted sharply with the efforts to standardize measurement procedures for FEV1 and FVC. The American Thoracic Society devoted a great deal of attention to studying these measures and published guidelines for the standardization of their measurement. These guidelines included detailed protocols for calibrating equipment, administering the tests, determining reproducibility, and interpreting results. The research provided data on the optimal number of trials per test session, the difference between a PEF performed during a full forced expiratory effort and that resulting from a short blast, the impact of test supervision on test performance, and the reproducibility of the PEF measurement. DESIGN NARRATIVE: A baseline survey of ventilatory function was performed using spirometry. PEF was measured daily with a mini-Wright Peak Flow Meter over a period of several weeks in a study of 201 normals (staff, faculty and graduate students at the University of Massachusetts Lowell). Serial PEF data were collected on a group of mild asthmatics identified in a local occupational medicine clinic. Finally, performance characteristics were examined in serial PEF data from two existing occupational cohort studies. The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record. |
||
Study Type | Observational | ||
Study Design | Not Provided | ||
Target Follow-Up Duration | Not Provided | ||
Biospecimen | Not Provided | ||
Sampling Method | Not Provided | ||
Study Population | Not Provided | ||
Condition |
|
||
Intervention | Not Provided | ||
Study Groups/Cohorts | Not Provided | ||
Publications * | Not Provided | ||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
Recruitment Information | |||
Recruitment Status | Completed | ||
Enrollment | Not Provided | ||
Original Enrollment | Not Provided | ||
Actual Study Completion Date | May 1998 | ||
Primary Completion Date | Not Provided | ||
Eligibility Criteria | No eligibility criteria | ||
Sex/Gender |
|
||
Ages | up to 100 Years (Child, Adult, Senior) | ||
Accepts Healthy Volunteers | No | ||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||
Listed Location Countries | Not Provided | ||
Removed Location Countries | |||
Administrative Information | |||
NCT Number | NCT00005382 | ||
Other Study ID Numbers | 4287 R01HL051975 ( U.S. NIH Grant/Contract ) |
||
Has Data Monitoring Committee | Not Provided | ||
U.S. FDA-regulated Product | Not Provided | ||
IPD Sharing Statement | Not Provided | ||
Responsible Party | Not Provided | ||
Study Sponsor | National Heart, Lung, and Blood Institute (NHLBI) | ||
Collaborators | Not Provided | ||
Investigators | Not Provided | ||
PRS Account | National Heart, Lung, and Blood Institute (NHLBI) | ||
Verification Date | November 2001 |